NCM · Biotechnology

OVID (OVID) Stock

$2.29 -2.97% NCM: OVID Healthcare

Valuation

MetricValue
Price$2.29
Market Cap$427.41M
P/E Ratio-5.81
P/B Ratio2.71
P/S Ratio42.41
EPS (TTM)$-0.47
52-Week High$3.10
52-Week Low$0.29
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-17.51%
ROA-21.82%
ROCE-32.06%
Gross Margin-614.29%
Operating Margin-600.00%
Net Margin-339.33%
Debt/Equity0.01
Current Ratio11.25

Annual Financials (USD)

Metric20212022202320242025
Revenue$208.0M$2.0M$0$1.0M$7.0M
Operating Profit$124.0M$-56.0M$-59.0M$-62.0M$-42.0M
Net Profit$123.0M$-54.0M$-52.0M$-26.0M$-17.0M
EPS$1.76$-0.77$-0.74$-0.37$-0.24
Op Margin59.6%-3696.4%-15122.7%-10933.8%-585.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$195.0M$155.0M$144.0M$92.0M$151.0M
Total Liabilities$15.0M$23.0M$56.0M$24.0M$20.0M
Cash$188.0M$45.0M$27.0M$26.0M$13.0M
Borrowings$0$17.0M$16.0M$15.0M$13.0M

Latest News

Ovid Therapeutics (OVID) Appoints Kevin Norrett as Chief Business Officer Insider Monkey · Jul 14, 2026 Ovid Therapeutics Names Kevin Norrett Chief Business Officer, Promotes CFO and Chief Strategy Officer MT Newswires · Jul 8, 2026 Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development GlobeNewswire · Jul 8, 2026 Ovid Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire · Jun 4, 2026 Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors GlobeNewswire · Jun 3, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$119.0M$-55.0M$-46.0M$-56.0M$-38.0M
Investing Cash Flow$-4.0M$-89.0M$-3.0M$55.0M$-50.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$116.0M$-143.0M$-18.0M$-1.0M$-13.0M
Free Cash Flow$118.0M$-57.0M$-46.0M$-56.0M$-38.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-17.03
EV / EBITDA—
FCF Yield-13.89%
Quick Ratio10.17
Interest Coverage—
Return 1Y242.86%
Return 3Y-32.96%
Return 5Y-33.33%

Ownership

Insiders Held7.04%
Institutions Held64.43%
Institutions Float Held69.31%
Institutional HolderSharesReport Date
RA Capital Management, L.P.10,714,0002026-03-31
Janus Henderson Group PLC10,714,0002026-03-31
Affinity Asset Advisors, Llc10,636,3182026-03-31
Eventide Asset Management LLC9,916,9112026-03-31
Adage Capital Partners GP L.L.C.6,163,7812026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CLNNClene Inc. $5.29 -1.86% -1.66 $54.53M 0.00%
CNTB $2.07 -1.67% -2.31 $130.02M 0.00%
CNTX $0.62 +4.47% -6.84 $56.69M 0.00%
IFRX $1.84 +6.98% -4.16 $132.91M 0.00%
IMA $5.69 +1.07% -1.49 $64.18M 0.00%

About OVID

OVID is led by CEO Margaret Alexander, employs 23 people, headquartered in US, publicly traded since 2017.

OVID stock trades at $2.29 with a market capitalization of $427.41M. The stock is valued at a price-to-earnings (P/E) ratio of -5.81, price-to-book of 2.71, price-to-sales of 42.41. Over the past 52 weeks the stock has ranged between $0.29 and $3.10, and currently trades 26.2% below its 52-week high.

On profitability, OVID generates a return on equity (ROE) of -17.51%, return on capital employed of -32.06%, an operating margin of -600.00%, a net profit margin of -339.33%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides